Resources

Resource centre

Webinar

Formulation strategies for poorly soluble molecules - Pharmaceutics and biopharmaceutics considerations

This presentation uses expert insight and case studies to explore formulation and solubility challenges and discuss the best strategies and technologies for advancing poorly soluble molecules, to deliver success.

Developing Palatable Pediatric Formulations

Developing Palatable Pediatric Formulations. This webinar explores how you can leverage taste masking, modelling & simulation, clinical PK and taste assessment studies to achieve program success.

Thermal rearrangement – Flow Chemistry_Case Study

Quotient Sciences seeking to improve the yield and purity of a US Biotech API intermediate using flow chemistry

API Development Case Study

Rapid development of a scalable route towards an analogue of a new drug substance, with definition of an optimal salt form for formulation

Biochemical Assay Optimization, Validation & Application Case Study

UK specialty-pharma company in need of biochemical assay for their regulatory non-clinical safety study

Stable Isotope Labelling Case Study

Multiple, biotechnology and large-pharma companies needing isotope labelling support for their ADME/hAME studies

Radiosynthesis via chemically unstable intermediate Case Study

US biopharmaceutical company seeking to improve stability of their chemically unstable API intermediate for radiochemical trials

Analytical and Microbiological support Case Study

UK Clinical Research Unit (CRU), developing intravenous (IV) products in need of analytical & microbiological support

Analysis of Insulin Analogues Case Study

European biotech company developing an NCE to fulfil an unmet patient need, required insulin analogue analysis to gain regulatory approval

Drug Substance Salt Selection Case Study

US Biopharmaceutical seeking drug substanceand salt screen selection for their molecule.

Global Clinical Trial Supplies

Quotient can ease the headache of global product supply logistics and accelerate your proof-of-concept timeline. We’ll develop and manufacture your drug product, and then seamlessly integrate into a flexible packaging, labelling & distribution strategy, tailored to your clinical trial.

The Integration of Drug Substance and Drug Product

This webinar will highlight how a fully integrated program can speed up transition from candidate selection to proof of concept and shorten the pathway to clinical development.

Scientific Posters

Application of Translational Pharmaceutics in Accelerating the Development of MR Dosage Forms

Poster presentation at NERDG 2021 Annual Meeting. In this poster we demonstrate an optimized approach to developing oral modified-release (MR) dosage forms using the Translational Pharmaceutics platform. This approach uses emerging human data to inform adjustment of formulation composition in an adaptive clinical study.

Bioanalysis Formulation Development Drug Substance Clinical Trial Manufacturing Commercial Manufacturing Clinical Pharmacology Data Sciences Drug Development Consulting

Ask us a question

We use cookies to help us to improve our site and enables us to the best possible service and customer experience. By clicking accept you are agreeing to let us share your data with select third parties for analytics and marketing purposes.